HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 247 filers reported holding HAEMONETICS CORP in Q4 2017. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,904,000 | +568.1% | 29,214 | +795.3% | 0.29% | +495.8% |
Q3 2020 | $285,000 | -2.1% | 3,263 | +29.0% | 0.05% | +41.2% |
Q4 2019 | $291,000 | -26.7% | 2,529 | -19.6% | 0.03% | -37.0% |
Q3 2019 | $397,000 | -48.8% | 3,147 | -64.5% | 0.05% | -31.6% |
Q1 2019 | $775,000 | -47.5% | 8,856 | -39.9% | 0.08% | -53.5% |
Q4 2018 | $1,475,000 | -20.1% | 14,745 | -8.5% | 0.17% | +66.7% |
Q3 2018 | $1,846,000 | -65.1% | 16,107 | -72.7% | 0.10% | -61.1% |
Q2 2018 | $5,286,000 | +518.2% | 58,941 | +404.3% | 0.26% | +482.2% |
Q1 2018 | $855,000 | -56.9% | 11,687 | -73.6% | 0.04% | -66.7% |
Q3 2017 | $1,984,000 | +442.1% | 44,210 | +377.6% | 0.14% | +462.5% |
Q2 2017 | $366,000 | -34.5% | 9,257 | -46.6% | 0.02% | -11.1% |
Q4 2015 | $559,000 | -25.6% | 17,326 | -25.4% | 0.03% | -27.0% |
Q3 2015 | $751,000 | +2.9% | 23,225 | +31.6% | 0.04% | +32.1% |
Q2 2015 | $730,000 | +3.4% | 17,654 | +12.3% | 0.03% | 0.0% |
Q1 2015 | $706,000 | +168.4% | 15,726 | +123.8% | 0.03% | +55.6% |
Q4 2014 | $263,000 | – | 7,026 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
Dean Capital Management | 15,309 | $812,000 | 0.70% |
Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |